Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
Clinical trial NCT06427798 · RECRUITING
Trial details
- NCT number
- NCT06427798
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-07
- Primary completion
- 2029-07-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.